Scott B. Delaney is Unichem Pharmaceuticals (USA), Inc.’s President and Chief Executive Officer – North America. He is also a member of the Company’s Board of Directors.
Scott is an accomplished leader with over 24 years of experience in brand and generic pharmaceutical management. He brings deep expertise in many areas of generic pharmaceutical management, including sales, marketing, contract negotiation, business development, manufacturing/distribution, third party payor management, product portfolio selection and product life cycle management.
Scott has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, Edenbridge Pharmaceuticals and Heritage Pharmaceuticals, Inc.
Scott earned his B.B.A. in Accounting/MIS from Baylor University and his M.B.A. from the McCombs Graduate School of Business, The University of Texas at Austin.
2015 Unichem Pharmaceuticals USA INC All Right Reserved
Designed And Developed By Vervelogic